Patent ID: 9453239
Filing Date: 2016-09-27
CPC Classification: A61K,A61P,C07K,C12N

Claim Text:
1. A pharmaceutical composition comprising a recombinant MVA virus comprising a sequence encoding an HIV Env antigen inserted into deletion site II of an MVA and a sequence encoding HIV Gag and Pol antigens inserted into deletion site III of the MVA genome, and a pharmaceutically acceptable carrier; wherein the sequence encoding the HIV Env antigen comprises SEQ ID NO:3 and the sequence encoding the HIV Gag and Pol antigens comprises SEQ ID NO: 4; wherein the transcription of the sequence encoding the HIV Env antigen is under the control of a first promoter and transcription of the sequence encoding the HIV Gag and Pol antigens is under the control of a second promoter and wherein the noncoding sequence between the first promoter and the initiation codon of the sequence encoding the HIV Env antigen comprises SEQ ID NO:8.